| The rationale for quadrivalent influenza vaccines CS Ambrose, MJ Levin Human vaccines & immunotherapeutics 8 (1), 81-88, 2012 | 471 | 2012 |
| The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials G De Serres, DM Skowronski, XW Wu, CS Ambrose Eurosurveillance 18 (37), 20585, 2013 | 281 | 2013 |
| An expert consensus framework for asthma remission as a treatment goal A Menzies-Gow, M Bafadhel, WW Busse, TB Casale, JWH Kocks, ... Journal of Allergy and Clinical Immunology 145 (3), 757-765, 2020 | 272 | 2020 |
| Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials J Rhorer, CS Ambrose, S Dickinson, H Hamilton, NA Oleka, FJ Malinoski, ... Vaccine 27 (7), 1101-1110, 2009 | 228 | 2009 |
| The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults CS Ambrose, MJ Levin, RB Belshe Influenza and other respiratory viruses 5 (2), 67-75, 2011 | 223 | 2011 |
| Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma GM Gauvreau, R Sehmi, CS Ambrose, JM Griffiths Expert opinion on therapeutic targets 24 (8), 777-792, 2020 | 209 | 2020 |
| Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity RB Belshe, K Coelingh, CS Ambrose, JC Woo, X Wu Vaccine 28 (9), 2149-2156, 2010 | 179 | 2010 |
| Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza CS Ambrose, C Luke, K Coelingh Influenza and other respiratory viruses 2 (6), 193-202, 2008 | 163 | 2008 |
| Burden of paediatric influenza in Western Europe: a systematic review EN Antonova, CE Rycroft, CS Ambrose, T Heikkinen, N Principi BMC public health 12, 1-16, 2012 | 146 | 2012 |
| Safety and efficacy of live attenuated influenza vaccine in children 2–7 years of age RB Belshe, CS Ambrose, T Yi Vaccine 26, D10-D16, 2008 | 143 | 2008 |
| The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies CS Ambrose, X Wu, M Knuf, P Wutzler Vaccine 30 (5), 886-892, 2012 | 132 | 2012 |
| Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age SL Block, R Yogev, FG Hayden, CS Ambrose, W Zeng, RE Walker Vaccine 26 (38), 4940-4946, 2008 | 132 | 2008 |
| The role of nasal IgA in children vaccinated with live attenuated influenza vaccine CS Ambrose, X Wu, T Jones, RM Mallory Vaccine 30 (48), 6794-6801, 2012 | 127 | 2012 |
| The efficacy of live attenuated influenza vaccine against influenza-associated acute otitis media in children SL Block, T Heikkinen, SL Toback, W Zheng, CS Ambrose The Pediatric infectious disease journal 30 (3), 203-207, 2011 | 97 | 2011 |
| Respiratory syncytial virus disease in preterm infants in the US born at 32–35 weeks gestation not receiving immunoprophylaxis CS Ambrose, EJ Anderson, EAF Simões, X Wu, H Elhefni, CL Park, ... The Pediatric infectious disease journal 33 (6), 576-582, 2014 | 96 | 2014 |
| Trends in respiratory syncytial virus and bronchiolitis hospitalization rates in high-risk infants in a United States nationally representative database, 1997–2012 A Doucette, X Jiang, J Fryzek, J Coalson, K McLaurin, CS Ambrose PLoS One 11 (4), e0152208, 2016 | 92 | 2016 |
| Efficacy of tezepelumab in severe, uncontrolled asthma: pooled analysis of the PATHWAY and NAVIGATOR clinical trials J Corren, A Menzies-Gow, G Chupp, E Israel, S Korn, B Cook, ... American journal of respiratory and critical care medicine 208 (1), 13-24, 2023 | 88 | 2023 |
| Hospitalizations for respiratory syncytial virus among adults in the United States, 1997–2012 ST Pastula, J Hackett, J Coalson, X Jiang, T Villafana, C Ambrose, ... Open forum infectious diseases 4 (1), ofw270, 2017 | 87 | 2017 |
| Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2–17 years of age in 2013–2014 in the United States H Caspard, M Gaglani, L Clipper, EA Belongia, HQ McLean, MR Griffin, ... Vaccine 34 (1), 77-82, 2016 | 87 | 2016 |
| Live-attenuated influenza vaccine effectiveness in children from 2009 to 2015–2016: a systematic review and meta-analysis H Caspard, RM Mallory, J Yu, CS Ambrose Open forum infectious diseases 4 (3), ofx111, 2017 | 85 | 2017 |